Madrigal Pharmaceuticals
MDGL
#2184
Rank
S$9.59 B
Marketcap
$440.06
Share price
5.74%
Change (1 day)
40.60%
Change (1 year)

EPS for Madrigal Pharmaceuticals (MDGL)

EPS in 2023 (TTM): -$25.45

According to Madrigal Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$25.28. In 2022 the company made an earnings per share (EPS) of -$23.35 a decrease over its 2021 EPS that were of -$19.80.

EPS history for Madrigal Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$25.459%
2022-$23.3517.93%
2021-$19.8011.61%
2020-$17.74140.18%
2019-$7.39146.61%
2018-$3.00-12.99%
2017-$3.44-91.03%
2016-$38.37-14.83%
2015-$45.056.71%
2014-$42.22-29.92%
2013-$60.2419.81%
2012-$50.286%
2011-$47.437.53%
2010-$44.11-139.74%
2009$111.00-185.4%
2008-$129.97-31.67%
2007-$190.2152.27%
2006-$124.91-27.65%
2005-$172.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.36-94.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.37-98.55%๐Ÿ‡บ๐Ÿ‡ธ USA